Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer

View source ↗

Summary

AstraZeneca-sponsored observational study evaluating how pathology practice uses artificial intelligence in patients suspected of lung cancer or breast cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Lung Cancer, Breast Cancer | Status: RECRUITING